Skip to main content

Vision-related quality of life among released from treatment cases of leprosy evaluated with NEI-VFQ-25: a cross-sectional study

Abstract

Background

People with leprosy who have been declared Release From Treatment (RFT) are often not aware of the leprosy sequelae possibility which can decrease their quality of life. This could be because they have been adapting for a long time hence they do not feel the need to see physicians. This study seeks to compare the results of Vision-Related Quality of Life (VR-QoL) among RFT persons based on the National Eye Institute Visual Functioning Questionnaire–25 (NEI-VFQ-25) and WHO grading disability based on physical examination.

Methods

A cross-sectional study of 325 RFT subjects from leprosy communities (Singkawang, West Kalimantan and Tangerang, Banten) was conducted between 2018 and 2019. We used the NEI-VFQ-25 questionnaire that had been validated and translated into Indonesian and distributed to the leprosy population. Relationships and comparisons among variables were evaluated using Kruskal–Wallis and Mann–Whitney tests.

Results

There were three main results: The median composite score of VR-QoL for WHO grade 0, 1, and 2 disabilities has decreased by 13%, 25.5%, and 30% of the maximum value, respectively. Of the total, eleven subscales were statistically significant between WHO grading disability and VR-QoL based on the NEI-VFQ-25 (p < 0.05). The comparison between grade 0 and grade 2 disability in all subscales was statistically significant (p < 0.05).

Conclusions

The grade of disability is related to their VR-QoL assessment using the NEI-VFQ-25 questionnaire. Thus, it can be used as an initial screening in primary healthcare settings to increase awareness of disability before a thorough physical examination.

Peer Review reports

Background

Leprosy is an infectious disease caused by Mycobacterium leprae, which primarily alters the skin, peripheral nerves, eyes, and other mucosae [1]. Delayed detection and inappropriate treatment can cause the disease to progress badly. The development of the damage can occur before, during, or after treatment. The high incidence and complications will lead to several causes such as physical impairment due to nerve damage and psychosocial impacts [2, 3].

The incidence of leprosy is declining, but not at the expected rate as reported by 161 countries in 2019 that a total of 202,185 new leprosy cases were discovered worldwide [4]. Brazil, India, and Indonesia were at the top of the list with more than 10,000 cases each [5]. In 2017, Indonesia announced 15,910 new cases of leprosy (6.1 / 100,000 populations) with 86.12% of cases including MultiBacillary (MB) type, and 61.99% of new leprosy patients were male [6]. Data from the Indonesian Ministry of Health in April 2021 showed that there were still 7 provinces that have not been eliminated from leprosy [7]. The World Health Organization (WHO) recently initiated a new global strategy for leprosy 2021–2030 entitled "Towards Zero Leprosy". The focus of attention on leprosy is now shifting more towards the prevention of disability through early case findings [8].

The WHO definition of Quality of Life (QoL) is a personal perception of their position in life, the culture and value systems in which they live, and their goals, standards, expectations, and concerns [9]. Leprosy has a great risk of permanent and progressive physical disability, thus causing an impact on a patient’s QoL. Studies conducted in India, Bangladesh, and Brazil demonstrated that the QoL of leprosy patients was worse than that of the general population [10, 11]. Although various efforts have been made to minimize the progression of disability in people with leprosy, there are still numbers of former leprosy patients who have recovered from the disease with residual defects that affect their limbs and eyes [12].

This study addressed a problem that is rarely highlighted nowadays: eye impairment in persons affected by leprosy that can occur while having treatment, in patients who experience a reaction to leprosy treatment (indirectly), or after the patients are declared RFT. Therefore, patients often ignore eye complaints because they feel they have completed their treatment.

In this study, we assessed QoL based on the questionnaire from the NEI-VFQ-25, which is usually used to assess QoL related to visual impairment. We aim to investigate whether this questionnaire could be used to assess the quality of life of RFT people with/without disabilities. In addition, the degree of disability, visual acuity, and the identification of possible correlations between these factors among RFT people in Indonesia are the merits of this paper. We recommend using this instrument to monitor and evaluate VR QoL among leprosy patients with visual impairments who have been released from treatment periodically; thus, the treatment can be given immediately to prevent further disability. This instrument can also be applied for patient screening prior to physical examination by an ophthalmologist.

Methods

A cross-sectional study was conducted in Singkawang, West Kalimantan and Tangerang, Banten, Indonesia between 2018 and 2019. The study was conducted by Cipto Mangunkusumo Hospital’s medical team titled KATAMATAKU (Identifikasi Tanda-tanda Kelainan Mata, Ekstremitas, dan Kulit pada Kusta), consisting of ophthalmologists, dermatologists, and medical rehabilitation specialists. The inclusion criteria were all former leprosy patients who had declared RFT and had given consent to participate, completed the VR-QoL questionnaire, and undergone all examination series during the program which included eye, skin, and extremities examinations. The exclusion criteria were leprosy patients who were still on leprosy medication based on the patient's acknowledgment and/or suffering from severe mental disorders or difficulty communicating based on the assessment of the research team onsite. Data were collected by interviewing and examining a total of 363 RFT persons in Singkawang and Tangerang, 325 subjects of whom met the eligibility criteria. Physical examination included the detection of signs and symptoms of leprosy such as abnormalities and deformities in the eyes (visual acuity using Snellen chart), and extremities (deformity, motoric and sensory nerve function).

To assess VR-QoL, we used the National Eye Institute 25-item Visual Function Questionnaire (NEI-VFQ-25) that had been validated and translated into Indonesian. It was administered by the interviewer as a printout at the study site. Subjects who were illiterate were assisted in filling out the questionnaire [13]. To prevent from being bias when assisting patients completing the questionnaire, the interviewers had been trained on how to ask the questions without directing the participants’ answers and to use language understood by the subjects. The selected interviewers were general practitioners and nurses who volunteered to participate in this program. They also received training for filling out the NEI-VFQ-25 questionnaire. We also provided interview guidance that could be learned by the selected interviewers.

The NEI-VFQ-25 targeted question subscales include global vision, difficulty with near vision activities, difficulty with distance vision activities, limitation in social functioning, role limitations due to vision, dependency on others due to vision, mental health symptoms due to vision, driving difficulties, limitations with peripheral, colour vision, and ocular pain [14]. Each subscale in the NEI-VFQ-25 is calculated based on the method that has been described by the developer and can range from 0 to 100, where 0 is the worst and 100 indicates the best related to vision quality of life. Mangione et al. measured quality of life using the NEI-VFQ-25 questionnaire because this questionnaire provides reproducible data and validity, especially if used in various conditions with varying degrees of eye disease severity. This questionnaire is also widely chosen because it is specific [15, 16].

Disability in leprosy is defined by the WHO grading system: Grade 0—absence of disability (no anaesthesia) and no visible damage or deformity on eyes, hands, or feet; Grade 1 − loss of protective sensibility on eyes, hands, and feet; Grade 2—presence of deformities or visible damage to the eyes, hands, or feet. The highest grade of disability of any of these body sites was used as an overall indicator of the disability status of an individual with leprosy. This assessment was used because some of the items in the NEI-VFQ-25 questionnaire not only require a healthy vision but are comprehensive with the extremities (e.g. walking downstairs and driving) [17, 18].

We performed two kinds of visual acuity examinations consisting of Uncorrected Visual Acuity (UCVA) without the use of trial glasses or lenses, and Best-Corrected Visual Acuity (BCVA) using trial lenses. Afterwards, we classified visual acuity into four classifications based on the World Health Organization of Vision Impairment Classification which are:

  • 1 = for no or mild visual impairment (visual acuity is ≥ 6/18), ≥ 0.33

  • 2 = for moderate visual impairment (visual acuity < 6/18 to ≥ 6/60), ≥ 0.10

  • 3 = for severe visual impairment (visual acuity is < 6/60 to ≥ 3/60) and ≥ 0.05

  • 4 = for blindness (visual acuity < 3/60 to no light perception) < 0,05 [19]

Statistical analysis

Statistical analysis was performed using SPSS for Macintosh version 25.0. IBM Corp. Released 2017. IBM SPSS Statistics for Windows, Version 25.0. Armonk, NY: IBM Corp. Data were presented in the form of tables, and narratives. Relationships and comparisons among and between variables were evaluated using ANOVA or Kruskal–Wallis test and Mann–Whitney test, the alpha level was set at p < 0.05.

Results

A total number of 325 subjects, consisting of 76 subjects from Singkawang and 249 from Tangerang, were analysed. Table 1 shows the comparison of subject characteristics in all RFT persons by demographic information. The mean age of the total subjects was 53.21 ± 12.32 years old. Subjects were predominantly males, in a 1.7:1 ratio compared to females. Most of the subjects (49.8%) had non-fixed income (taxi bike drivers, construction workers, stall owners, and freelancers). Nearly half of them were uneducated (47.4%).

Table 1 Demographic data of RFT persons, Singkawang and Sitanala Indonesia, 2018–2019

As shown in Table 2, based on WHO disability grading, 66 (20.3%) subjects were in grade 0, 11 (3.4%) subjects were in grade 1, while 248 (76.3%) subjects were in grade 2. The majority of the subjects were diagnosed with MultiBacillary (MB) type of leprosy when they were first examined (84.6%), and had a duration of leprosy above 5 years (51.4%). Despite the highest number of subjects being in grade 2 disability, 76.6% of the patients still had no or mild visual impairment. This is due to as many as 54 (16.6%) subjects having grade 2 disability in their eyes, 227 (69.8%) in hands, and 234 (72.2%) in their feet. However, the difference in scores between these groups was not statistically significant (p = 0.77).

Table 2 Clinical characteristics of RFT persons, Singkawang and Sitanala Indonesia, 2018–2019 based on WHO disability grading

Table 3 shows Uncorrected Visual Acuity (UCVA) and Best-Corrected Visual Acuity (BCVA) examination results. More than half of the subjects were classified as having mild or no visual impairment according to the WHO Vision Impairment Classification. We can see that there were improvements in all classifications when the subjects were best-corrected with lenses, so it may indicate that Uncorrected Refractive Error (URE) was the majority cause of visual impairment and blindness in these subjects.

Table 3 Distribution of visual impairment in RFT persons, Singkawang and Sitanala Indonesia, 2018–2019 based on WHO classification for visual acuity

The total quality of life score (composite score) is the average of 10 to 11 subscale scores obtained from the average of the scores for each question in the NEI-VFQ-25 questionnaire in this study. The revised scoring algorithm excludes the single-item general health rating question from the calculation of the vision-targeted composite score. The maximum score in the normal population without impairment is 100 (100%) [20]. The mean total quality of life score in each grade based on WHO disability grading is shown in Table 4. The median total quality of life score for all subjects in grade 0 is 87 (30–100), in grade 1 74.5 (50–98), and in grade 2 70 (13–98), which means that for all subjects, there has been a decrease in quality of life about 13%, 25.5% and 30% of the maximum value in each grade, respectively. These three median differences were statistically significant (p < 0.001).

Table 4 Comparison between WHO Grade of Disability and VRQoL classification based on NEI-VFQ-25 in RFT persons, Singkawang and Sitanala Indonesia, 2018–2019 (n = 325)

General health denoted the lowest median score in all severity grades among all questions, while colour vision had the highest median score for all severity grades. The median score on the near vision subscale was worse than the distance vision, and this can be caused by the average age of patients in this study, which was over 50 years old. Of the total eleven subscales we analysed, there was a significant relationship between the WHO Disability Grading and the VR-QoL Classification based on the NEI-VFQ-25 (p < 0.05). We excluded the driving subscale due to the high missing rate in this population.

Afterward, we assessed each subscales and determined disability grade 0 as our reference because it was considered as not having any disability compared to WHO disability grade 1 and 2. Using the Mann–Whitney test as shown in Table 5, we concluded when VR-QoL compared to grade 0 and grade 1, disability groups were almost entirely not statistically significant, only the ocular pain and near vision subscales were significantly different. In contrast, in the comparison between grade 0 and grade 2 disability, all subscales were statistically significant.

Table 5 Comparison between WHO grade of disability and VRQoL classification based on NEI-VFQ-25 using grade 0 of disability as a reference in former leprosy patients, Singkawang and Sitanala Indonesia, 2018–2019 (n = 325)

Discussion

This study evaluates the relationship between vision-related quality of life and the grade of disability among RFT persons in Indonesia. In this study, subjects were predominantly men, and this was similar to the study by Peters et al. in Nigeria which found that the ratio between males to females was 2:1 from a total of 1527 patients [21]. Various studies have reported that the proportion of women affected with leprosy was lower than men. This finding may be due to the underreporting of female leprosy cases. A study from Nepal has stated some factors which were responsible for these under-reported cases, some of which are women with leprosy were illiterate, got married early, had a heavy workload, had poor knowledge, and were unaware of leprosy signs and symptoms. However, in the current study, we have not further analysed the data about women with leprosy in Indonesia; thus, further investigation regarding behavioural characteristics and cultural aspects of female leprosy cases is highly recommended [22].

This study also revealed that the number of uneducated subjects was considerably high with 47% cases and most of the subjects had non-fixed income with 49.8% cases. Our findings are consistent with Mankar et al. study from India which stated the number of illiterate subjects was the highest and most of them were farmers or sedentary workers [10]. We can assume from these conditions that RFT persons will have low health awareness which leads to delayed diagnosis and treatment. Consequently, this delay may lead to an even more severe disability sequel despite the completion of MDT. To increase patient awareness, we can carry out primary prevention activities through education and screening programs. As we have been doing so far in the KATAMATAKU program, the activities consist of preventive, promotive, curative, and rehabilitative aspects for the management of leprosy patients, and during the implementation of the program, we usually collaborate with the community, stakeholders, local government, and academicians. The KATAMATAKU program has also included vision screening and the prescription of glasses for leprosy patients with visual impairment.

Visual impairment in RFT persons revealed that most of the subjects suffered from no or mild visual impairment. It represents 5.2% of blindness in UCVA, but if their visual acuity is corrected with glasses, it improves to 4.0%, while the 28% of the subjects with moderate visual impairment in UCVA can improve to 16% after being corrected with glasses (Table 3). Early visual acuity screening and the use of glasses to reduce visual impairment play an important role in Leprosy surveillance programs, particularly in MB cases where the disability is higher. This finding is similar to a study by Thompson et al. which found that 2.9% patients were blind and 20.7% had a moderate visual impairment [23].

Quality of life has 5-dimensional aspects which include aspects of vision, economic, social, functional aspects (self-care, mobility, activity level, activity of daily living), as well as psychological and emotional aspects (cognitive function, emotional well-being) [24]. In the NEI-VFQ-25 questionnaire, there is a driving subscale which we excluded because there were only 105 (32.3%) subjects who claimed to be able to drive, 35 (10.8%) had to stop driving, while the other 185 (67.7%) were never driving or did not want to answer this section. Of those subjects who were able to drive, only 56 subjects claimed to be able to drive a car, while this section of the questionnaire was specially made for car driving, not other vehicles like motorcycles or bicycles which are common transportation in Indonesia. The possible explanation for this situation was the poor economic state of mostly leprosy patients in Indonesia. A similar possible explanation in other studies from different populations also showed a high percentage of missing values for the ‘Driving’ subscale [25].

Most subjects in this study had almost entered the geriatric age. Leprosy amongst the elderly deserves attention because of the increased susceptibility to having a disability in this age group, with their higher risk of reaction, their greater level of comorbidity, resulting in low quality of life. The same result showed by the study of Bello et al. which found low Health-Related Quality of Life (HRQoL) among their samples, those of whom were the elderly patients affected by leprosy in South Ghana [12]. Okpo et al. also reported in their study in Kano State, Nigeria that the prevalence of low vision and blindness among their subjects was high, which may be due to the subjects they studied experiencing complications of ocular leprosy and/or as part of the age-appropriate degenerative process of the subjects.25 Another study in Cameroon also stated that the prevalence of visual disability in leprosy patients was very high, but only one-third of the cases were due to complications of leprosy that they suffered, since most of which were caused by age-related pathological processes [26].

Using grade 0 of WHO disability grading as a reference, nearly all parameters are statistically insignificant between disability grade 1 and the vision-related quality of life. In contrast, the comparison between grade 0 and grade 2 disability showed all subscales were statistically significant that may make daily life activities difficult in the beginning (see Table 5). Regardless of their disability, after a long time of getting used to living with their disability, they were finally able to adapt and carry out daily activities. This result appeared to be similar to the study by Prado et al. in Brazil which concluded that disability grades do influence the physical activity of leprosy patients. There is an assumption that neural involvement in limbs and eyes occurs slowly [27]. They slowly develop new ways of holding objects, allowing them to perform routine activities independently. Our study also shows that most of the subjects suffering from leprosy for more than 5 years 167 (51.4%) had adapted to their limitations. On the other hand, loss of protective sensation increases the risk of injury and can result in loss of integrity of the affected organ resulting in new disability.

Leprosy mainly affects peripheral nerves in the extremities and eyes. In our report, subjects who were uneducated and had non-fixed income were the highest number among others; thus, education and individual skills are two substantial points for subjects to get a better job and higher income. Negative stigma from the community towards people affected by leprosy is assumed to highly influence the opportunity of leprosy patients from obtaining decent employment due to their disabilities. Therefore, the stigma regarding leprosy patients that still persists in the community should be removed, so they can be accepted well in their surroundings and have a suitable chance for work. To conclude, the use of the NEI-VFQ-25 questionnaire that has been analysed in this study can be beneficial for the improvement of clinical management in leprosy patients in terms of initial screening in primary health care settings and monitoring of leprosy patients to prevent further disability and improve QoL of the patients.

The limitation of this study is the biased sample, as non-random samples from a settlement of elderly former leprosy patients near Jakarta and Singkawang were used, and the cross-sectional study design. Furthermore, we suggest that the NEI-VFQ-25 questionnaire needs to be modified, especially the driving sub-scales, because these questions were not applicable, especially in low economic settings.

Conclusion

In conclusion, in regards to the VR-QoL assessment compared with disability grading, it is noteworthy that the disabilities of the eye, hand, and foot affect their VR-QoL. Subjective results based on the questionnaire were in concordance with objective results from the examination.

The NEI-VFQ-25 seems applicable to measure the VR-QoL of RFT persons with leprosy cases and can be used as an initial screening in primary health care settings to increase awareness of their disability before a thorough physical examination. We hope that eye health services can be expanded to these people so that their vision and consequently their VR-QoL can be improved with a pair of glasses or cataract surgery. Further research with a larger number of subjects is still needed, especially in more endemic locations.

Availability of data and materials

The datasets analysed during the current study are not publicly available but are available from the corresponding author upon reasonable request.

Abbreviations

BCVA:

Best-Corrected Visual Acuity

KATAMATAKU:

Identifikasi Tanda-tanda Kelainan Mata, Ekstremitas, dan Kulit pada Kusta

MB:

MultiBacillary

N/A:

Not Available

NEI-VFQ-25:

National Eye Institute Visual Functioning Questionnaire–25

PB:

PauciBacillary

QoL:

Quality of Life

RFT:

Release From Treatment

UCVA:

UnCorrected Visual Acuity

VR-QoL:

Vision-Related Quality of Life

WHO:

World Health Organization

References

  1. Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL. The continuing challenges of leprosy. Clin Microbiol Rev. 2006;19:338–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Lastória JC, de Abreu MAMM. Leprosy: review of the epidemiological, clinical, and etiopathogenic aspects - Part 1. An Bras Dermatol. 2014;89:205–18.

    Article  PubMed  PubMed Central  Google Scholar 

  3. da Silva Viana L, de Aguiar MI, de Vasconcelos PF, de Aquino DM. Aspecto físico e as repercussôes na qualidade de vida e autonomia de idosos afetados por hanseníase. Eglobal. 2017;16:336.

    Article  Google Scholar 

  4. World Health Organization Leprosy (Hansen’s disease). World Health Organization; 2021.

  5. World Health Organization. Global leprosy (Hansen disease) update, 2019: time to step-up prevention initiatives. 2020;419

  6. Sutarjo US, Kurniawan R, Yudianto HB, Siswanti T. Indonesia’s Health Profile 2017. Jakarta: Ministry of Health Republic of Indonesia; 2018.

    Google Scholar 

  7. Ministry of Health of the Republic of Indonesia (2021) Kemenkes Berikan Penghargaan Kepada Wilayah Yang Berhasil Capai Eradikasi Frambusia dan Eliminasi Kusta. In: Directorate general of disease prevention and control. http://p2p.kemkes.go.id/kemenkes-berikan-penghargaan-kepada-wilayah-yang-berhasil-capai-eradikasi-frambusia-dan-eliminasi-kusta/. Accessed 19 May 2021.

  8. World Health Organization. Towards zero leprosy. Global leprosy (Hansen’s Disease) strategy 2021–2030. World Health Organization SEARO, New Delhi. 2021

  9. World Health Organization. The World Health Organization quality of life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995;41:1403–9.

    Article  Google Scholar 

  10. Mankar M, Joshi S, Velankar D, Mhatre R, Nalgundwar A. A comparative study of the quality of life, knowledge, attitude and belief about leprosy disease among leprosy patients and community members in Shantivan Leprosy rehabilitation centre, Nere, Maharashtra. India J Global Infect Dis. 2011;3:378.

    Article  Google Scholar 

  11. Proto RS, Machado Filho CDS, Rehder JRCL, Paixão MP, Angelucci RI. Quality of life in leprosy: a comparative analysis between patients in the Amazon region and patients in Santo André in the ABC region of São Paulo, Brazil. An Bras Dermatol. 2010;85:939–41.

    Article  PubMed  Google Scholar 

  12. Bello AI, Dengzee SA, Iyor FT. Health related quality of life amongst people affected by leprosy in South Ghana: a needs assessment. Lepr Rev. 2013;84:76–84.

    Article  PubMed  Google Scholar 

  13. Rahayu T, Menaldi SL, Irawati Y, Adriono GA, Presialia A, Harini M, Friska D. Validity and reliability of the NEI-VFQ-25 questionnaire in Indonesian leprosy patients. Clin Epidemiol Global Health. 2022;15:101039.

    Article  CAS  Google Scholar 

  14. Sivaprasad S, Tschosik E, Kapre A, Varma R, Bressler NM, Kimel M, Dolan C, Silverman D. Reliability and construct validity of the NEI-VFQ-25 in a subset of patients with geographic atrophy from the phase 2 mahalo study. Am J Ophthalmol. 2018;190:1–8.

    Article  PubMed  Google Scholar 

  15. Mangione CM. Development of the 25-list-item National eye institute visual function questionnaire. Arch Ophthalmol. 2001;119:1050.

    Article  CAS  PubMed  Google Scholar 

  16. Simangunsong C, Artini W, Mustafa S Comparison of quality of life in moderate and advanced stages Glaucoma patients. Universitas Indonesia

  17. Brandsma JW, Van Brakel WH. WHO disability grading: operational definitions. Lepr Rev. 2003;74:366–73.

    Article  PubMed  Google Scholar 

  18. Organization WH, editor. International classification of functioning, disability and health: ICF. Geneva: World Health Organization; 2001.

    Google Scholar 

  19. Steinmetz JD, Bourne RRA, Briant PS, et al. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study. Lancet Glob Health. 2021;9:e144–60.

    Article  Google Scholar 

  20. Asroruddin M. The Impact of Impaired Vision and Eye Disease on Vision-Related Quality of Life in the Population Severe Visual Impairment and Blindness in Indonesia Sub-study Data Validation Study Blindness Riskesdas 2013 Results and Identification of Etiology. Universitas Indonesia; 2014.

  21. Peters ES, Eshiet AL. Male-female (sex) differences in leprosy patients in south eastern Nigeria: females present late for diagnosis and treatment and have higher rates of deformity. Lepr Rev. 2002;73:262–7.

    Article  CAS  PubMed  Google Scholar 

  22. Sarkar R, Pradhan S. Leprosy and women. Int J Women’s Dermatol. 2016;2:117–21.

    Article  Google Scholar 

  23. Thompson KJ, Allardice GM, Babu GR, Roberts H, Kerketta W, Kerketta A. Patterns of ocular morbidity and blindness in leprosy–a three centre study in Eastern India. Lepr Rev. 2006;77:130–40.

    Article  PubMed  Google Scholar 

  24. World Health Organization WHOQOL : measuring quality of life. World Health Organization. World Health Organization. Division of Mental Health and Prevention of Substance Abuse, Geneva; 1997.

  25. Mollazadegan K, Huang J, Khadka J, Wang Q, Yang F, Gao R, Pesudovs K. Cross-cultural validation of the National eye institute visual function questionnaire. J Cataract Refract Surg. 2014;40:774–84.

    Article  PubMed  Google Scholar 

  26. Eballé AO, Owono D, Book AU, Bella AL, Mvogo CE, Mba N. Prevalence and etiologies of visual handicaps in leprosy patients in the south of Cameroon. Clin Ophthalmol. 2009;3:195–8.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Do Prado GD, Prado RBR, Marciano LHSC, Nardi SMT, Cordeiro JA, Monteiro HL. WHO disability grade does not influence physical activity in Brazilian leprosy patients. Lepr Rev. 2011;82:270–8.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank all the participants, especially the residents of Sitanala settlement village, Mrs. Ollin MD, and the former leprosy patients of Alverno Hospital. We also acknowledge Sitanala Hospital, Alverno Hospital, Topcon Industries, and Cendo Company for their medical equipment and medicament support, Directorate of Research and the Community Engagement University of Indonesia, and Directorate P2 of Direct Transmitted Disease Director-General P2P Health Ministry of Indonesia.

Funding

This program was supported by the Community Engagement Grant of 2018 (NKB-1325/UN2.R3.1/HKP.05.00/2019) and 2019 (NKB-3050/UN2.R3.1/HKP.05.00/2019) DRPM (Directorate of Research and Community Engagement) Universitas Indonesia.

Author information

Authors and Affiliations

Authors

Contributions

YI, GA, TR, and HZ wrote the manuscript, collected and analyzed data, performed the experiment, discussed the results as well as contributed to the conception, design, analysis, and interpretation of data. APB, HD, MS, YDL, DF, MH, SLM, DRK and CP wrote the manuscript and contributed to its analysis and interpretation of data. All authors reviewed and approved the final manuscript.

Corresponding author

Correspondence to Yunia Irawati.

Ethics declarations

Ethics approval and consent to participate

The study protocol was approved by the Ethics Committee of the Faculty of Medicine, Universitas Indonesia and consideration of the principles proposed by the Helsinki Declaration under the number CAAE: 0310/UN2.F1/ETIK/2018.

All former leprosy patients were informed about the objectives of the study and invited to participate. For illiterate participants, we orally presented the consent materials and then allowed sufficient time for questions to be asked and answered, both by the subject and by the person obtaining consent to ensure that the subject comprehends the consent information, while having an impartial witness observe the consent process. Those who agreed signed the informed consent form. Specifically for illiterate participants, all informed consents were obtained from their legal guardians.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Irawati, Y., Andayani, G., Rahayu, T. et al. Vision-related quality of life among released from treatment cases of leprosy evaluated with NEI-VFQ-25: a cross-sectional study. BMC Ophthalmol 23, 398 (2023). https://doi.org/10.1186/s12886-023-03146-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12886-023-03146-2

Keywords